Leveraging Blockchain to accelerate Clinical Trials
We are a team of business professionals passionate about solving the challenges facing the Healthcare & Pharma industry in drug development.
Our team of founders and advisors consists of individuals with extensive industry experience in innovation, drug development, business management and clinical operations
Our strengths are in Pharma value chain, Business Processes, Strategy and Blockchain technologies.
Our advisors have M.D’s/PhD’s from leading institutions
Rama K Rao
CEO & Co-founder
Rama is a senior executive with 27 years of extensive experience in the pharmaceutical industry with Eli Lilly and Novartis. He worked in a multiplicity of senior executive roles including being the Global Head for Development Finance for Novartis Oncology, the Head of Development Finance for US and the CFO of Novartis Pharma in Canada/Russia.
Clinical Advisory Board
- Dr. Michael Munzar (MD)
- Dr. Stephen Cunningham (MB, Bch, BAO, MD, FRCP, FFPM)
- Dr. Wilson Miller (MD)
Commercial Advisory Board
- Mr. Peter Droc (Vice President Global Marketing)
- Dr. Scott Motyka (PhD, MBA, MS)
I.T. & Innovation Advisory Board
- Dr. Gita Mathur PhD, DBA (Harvard Business School)
- Dr. Deborah Soule DBA (Harvard Business School)
Supporting speedier drug development for patients…
“Bloqcube’s system is very well thought through, covers the data typically collected across a broad range of disease fields, and can be customized to individual studies’ needs.. a one-stop-shop for all aspects of planning, implementation, resourcing and financially controlling clinical research.
…this system is unique across the medical research landscape. It streamlines tasks, enhances speed, and importantly, leads to greater data accuracy and data security (innovative blockchain technology). Data accuracy will likely be further improved through the system’s interactive messaging systems which will connect and engage everyone involved in a clinical study, thus facilitating an integrated team approach across the traditional operational silos in medicine.
Especially for a non-profit R&D organization like ours, the operational streamlining and cost savings are highly valuable, and I can highly recommend this system’s consideration when planning future studies- as I do.”
-Thomas Bock, MD, MBA
CEO, HeritX Inc.
“The system is unique, intuitive and fast. The clinical trial suite uses and integrates iPad based systems with a user-friendly front end. The proprietary C2TA system integrated with financial software gives real-time transparency. For the first time, this unique system unlocks the value of blockchain technology and distributed ledgers to drive real advantages for companies and investigators conducting clinical trials:
- Faster input and transfer of immutable and secure data
- Smart contracts and eCRF’s facilitate automation and accelerate the clinical process”
– Stephen Cunningham, MB, Bch, BAO, MD, FRCP, FFPM
Former CSO; Head of Clinical Dept. & Medical Affairs – Novartis, USA